Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design

Abstract Background Gamma (γ) brain oscillations are dysregulated in Alzheimer’s disease (AD) and can be modulated using transcranial alternating stimulation (tACS). In the present paper, we describe the rationale and design of a study assessing safety, feasibility, clinical and biological efficacy,...

Full description

Bibliographic Details
Main Authors: Daniele Altomare, Alberto Benussi, Valentina Cantoni, Enrico Premi, Jasmine Rivolta, Chiara Cupidi, Alessandro Martorana, Emiliano Santarnecchi, Alessandro Padovani, Giacomo Koch, Barbara Borroni
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Alzheimer’s Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13195-023-01297-4
_version_ 1827724196914921472
author Daniele Altomare
Alberto Benussi
Valentina Cantoni
Enrico Premi
Jasmine Rivolta
Chiara Cupidi
Alessandro Martorana
Emiliano Santarnecchi
Alessandro Padovani
Giacomo Koch
Barbara Borroni
author_facet Daniele Altomare
Alberto Benussi
Valentina Cantoni
Enrico Premi
Jasmine Rivolta
Chiara Cupidi
Alessandro Martorana
Emiliano Santarnecchi
Alessandro Padovani
Giacomo Koch
Barbara Borroni
author_sort Daniele Altomare
collection DOAJ
description Abstract Background Gamma (γ) brain oscillations are dysregulated in Alzheimer’s disease (AD) and can be modulated using transcranial alternating stimulation (tACS). In the present paper, we describe the rationale and design of a study assessing safety, feasibility, clinical and biological efficacy, and predictors of outcome of a home-based intervention consisting of γ-tACS over the precuneus. Methods In a first phase, 60 AD patients will be randomized into two arms: ARM1, 8-week precuneus γ-tACS (frequency: 40 Hz, intensity: 2 mA, duration: 5 60-min sessions/week); and ARM2, 8-week sham tACS (same parameters as the real γ-tACS, with the current being discontinued 5 s after the beginning of the stimulation). In a second phase, all participants will receive 8-week γ-tACS (same parameters as the real γ-tACS in the first phase). The study outcomes will be collected at several timepoints throughout the study duration and include information on safety and feasibility, neuropsychological assessment, blood sampling, electroencephalography, transcranial magnetic stimulation neurotransmitter measures, and magnetic resonance imaging or amyloid positron emission tomography. Results We expect that this intervention is safe and feasible and results in the improvement of cognition, entrainment of gamma oscillations, increased functional connectivity, reduction of pathological burden, and increased cholinergic transmission. Conclusions If our expected results are achieved, home-based interventions using γ-tACS, either alone or in combination with other therapies, may become a reality for treating AD. Trial registration PNRR-POC-2022–12376021.
first_indexed 2024-03-10T22:11:19Z
format Article
id doaj.art-5d54ca9fdcc74997a5b33fc7902b50f3
institution Directory Open Access Journal
issn 1758-9193
language English
last_indexed 2024-03-10T22:11:19Z
publishDate 2023-09-01
publisher BMC
record_format Article
series Alzheimer’s Research & Therapy
spelling doaj.art-5d54ca9fdcc74997a5b33fc7902b50f32023-11-19T12:35:43ZengBMCAlzheimer’s Research & Therapy1758-91932023-09-011511910.1186/s13195-023-01297-4Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study designDaniele Altomare0Alberto Benussi1Valentina Cantoni2Enrico Premi3Jasmine Rivolta4Chiara Cupidi5Alessandro Martorana6Emiliano Santarnecchi7Alessandro Padovani8Giacomo Koch9Barbara Borroni10Department of Clinical and Experimental Sciences, Neurology Unit, University of BresciaDepartment of Clinical and Experimental Sciences, Neurology Unit, University of BresciaDepartment of Clinical and Experimental Sciences, Neurology Unit, University of BresciaStroke Unit, ASST Spedali CiviliDepartment of Clinical and Experimental Sciences, Neurology Unit, University of BresciaNeurology Unit, Fondazione Istituto G. GiglioDepartment of Systems Medicine, Memory Clinic, University of Rome Tor Vergata Department of Radiology, Precision Neuroscience and Neuromodulation Program, Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical SchoolDepartment of Clinical and Experimental Sciences, Neurology Unit, University of BresciaDepartment of Clinical and Behavioral Neurology, Fondazione Santa Lucia IRCCSDepartment of Clinical and Experimental Sciences, Neurology Unit, University of BresciaAbstract Background Gamma (γ) brain oscillations are dysregulated in Alzheimer’s disease (AD) and can be modulated using transcranial alternating stimulation (tACS). In the present paper, we describe the rationale and design of a study assessing safety, feasibility, clinical and biological efficacy, and predictors of outcome of a home-based intervention consisting of γ-tACS over the precuneus. Methods In a first phase, 60 AD patients will be randomized into two arms: ARM1, 8-week precuneus γ-tACS (frequency: 40 Hz, intensity: 2 mA, duration: 5 60-min sessions/week); and ARM2, 8-week sham tACS (same parameters as the real γ-tACS, with the current being discontinued 5 s after the beginning of the stimulation). In a second phase, all participants will receive 8-week γ-tACS (same parameters as the real γ-tACS in the first phase). The study outcomes will be collected at several timepoints throughout the study duration and include information on safety and feasibility, neuropsychological assessment, blood sampling, electroencephalography, transcranial magnetic stimulation neurotransmitter measures, and magnetic resonance imaging or amyloid positron emission tomography. Results We expect that this intervention is safe and feasible and results in the improvement of cognition, entrainment of gamma oscillations, increased functional connectivity, reduction of pathological burden, and increased cholinergic transmission. Conclusions If our expected results are achieved, home-based interventions using γ-tACS, either alone or in combination with other therapies, may become a reality for treating AD. Trial registration PNRR-POC-2022–12376021.https://doi.org/10.1186/s13195-023-01297-4Alzheimer’s diseaseElectrical stimulationtACSBiomarkersCognitionMemory
spellingShingle Daniele Altomare
Alberto Benussi
Valentina Cantoni
Enrico Premi
Jasmine Rivolta
Chiara Cupidi
Alessandro Martorana
Emiliano Santarnecchi
Alessandro Padovani
Giacomo Koch
Barbara Borroni
Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design
Alzheimer’s Research & Therapy
Alzheimer’s disease
Electrical stimulation
tACS
Biomarkers
Cognition
Memory
title Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design
title_full Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design
title_fullStr Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design
title_full_unstemmed Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design
title_short Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design
title_sort home based transcranial alternating current stimulation tacs in alzheimer s disease rationale and study design
topic Alzheimer’s disease
Electrical stimulation
tACS
Biomarkers
Cognition
Memory
url https://doi.org/10.1186/s13195-023-01297-4
work_keys_str_mv AT danielealtomare homebasedtranscranialalternatingcurrentstimulationtacsinalzheimersdiseaserationaleandstudydesign
AT albertobenussi homebasedtranscranialalternatingcurrentstimulationtacsinalzheimersdiseaserationaleandstudydesign
AT valentinacantoni homebasedtranscranialalternatingcurrentstimulationtacsinalzheimersdiseaserationaleandstudydesign
AT enricopremi homebasedtranscranialalternatingcurrentstimulationtacsinalzheimersdiseaserationaleandstudydesign
AT jasminerivolta homebasedtranscranialalternatingcurrentstimulationtacsinalzheimersdiseaserationaleandstudydesign
AT chiaracupidi homebasedtranscranialalternatingcurrentstimulationtacsinalzheimersdiseaserationaleandstudydesign
AT alessandromartorana homebasedtranscranialalternatingcurrentstimulationtacsinalzheimersdiseaserationaleandstudydesign
AT emilianosantarnecchi homebasedtranscranialalternatingcurrentstimulationtacsinalzheimersdiseaserationaleandstudydesign
AT alessandropadovani homebasedtranscranialalternatingcurrentstimulationtacsinalzheimersdiseaserationaleandstudydesign
AT giacomokoch homebasedtranscranialalternatingcurrentstimulationtacsinalzheimersdiseaserationaleandstudydesign
AT barbaraborroni homebasedtranscranialalternatingcurrentstimulationtacsinalzheimersdiseaserationaleandstudydesign